Jan 17, 2023 | UC Irvine News

UC Irvine, UCLA researchers identify new therapeutic approach to prevent ARDS

A novel peptide designed by University of California, Irvine researchers has been found to suppress the damaging lung inflammation seen in acute respiratory distress syndrome, or ARDS. Their study, which appears in iScience, describes the first specific treatment designed to prevent the deadly disease, which can appear in patients with severe lung injury from infections with bacteria and viruses, like pneumonia, flu, respiratory syncytial virus (RSV) and COVID-19.

Dec 21, 2022 | UC Irvine News

UC Irvine-led study links metabolism changes in certain brain cells to Huntington’s disease — Findings show high-dose thiamine and biotin treatments can restore normal processes

A research team led by the University of California, Irvine has linked the mutation that causes Huntington’s disease to developmental deficits in the brain’s oligodendrocyte cells that are caused by changes in metabolism.

Dec 19, 2022 | UC Irvine School of Medicine

UCI-led study shows cognitively impaired degu is a natural animal model well suited for Alzheimer’s research; Chilean degu rodents display behavioral and neuropathological features that resemble human Alzheimer’s Disease

Led by researchers from the University of California at Irvine, a new study reveals that a long-lived Chilean rodent, called Octodon degus (degu), is a useful and practical model of natural sporadic Alzheimer’s Disease.

Dec 08, 2022 | UC Irvine News

Two UCI researchers named fellows by the National Academy of Inventors

Philip Felgner and Payam Heydari recognized for innovations that benefit society